BioCEP — raw details

Highlights

1 patent

About

Cell Isolation Platform

BioCEP develops, manufactures, and sells technologies for cell isolation to customers worldwide. The companys patented Cell Enrichment Process for Isolation of Rare Cells (CEPir) device enables effective immunomagnetic cell isolation for research and development. The CEPir isolates rare cells at high purity and recovery rates, offering an alternative to traditional solutions. The device is for research use only and is not intended for clinical or therapeutic use. BioCep is also currently developing applications in noninvasive prenatal testing and stem cell separation based on its technology. BioCEP is certified according to ISO 13485.

Identity

Name	BioCEP
Slug	biocep
Type / kind	startup
Crunchbase ID	biocep
Source _id	agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6usfgKDA

Status

Status	inactive
Status reason	Non Active, Sep 2021 ceased to operate
Last update	2026-05-17

Location

HQ country code	IL
HQ region/district	North District
HQ city	Yokne'am Illit
HQ address	HaYetsira 13, Yokne'am Illit, Israel

Web & social

LinkedIn	https://www.linkedin.com/company/475853
Twitter / X	https://twitter.com/biocepltd

Classifications

Primary sector Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesPharma & Medical BiotechnologyTest Diagnostics & ScreeningIndustrial Technologies

Technologies

BiologicalsCells

Target customers

Healthcare & Life SciencesHealthcareProvidersLaboratoriesLife SciencesBiotechnologyCommerce & RetailDistribution ChannelsDistributorIndustrial ManufacturingIndustrial EquipmentEducation

Business models

B2B

Funding

Total raised	$6.8M
Current stage	Mature

Raw source document

Show full JSON (0 KB)

{
  "0": "s",
  "1": "l",
  "2": "i",
  "3": "m",
  "4": "p",
  "5": "a",
  "6": "g",
  "7": "e",
  "8": "s",
  "9": "_",
  "10": "i",
  "11": "m",
  "12": "p",
  "13": "o",
  "14": "r",
  "15": "t"
}